JMX-15525-64119
3 vaccinations
4 coded responses
29 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 967 / HI
- Registered
- 2021-05-16
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
53W-22464-98976
Child or adolescent in my care · Male · 2021-11-16
Timeline
-
2021-04-23
Dose 1 — Pfizer-BioNTech
-
2021-05-14
Dose 2 — Pfizer-BioNTech
-
2021-05-16
Registered in v-safe
-
2021-05-16
Survey response — days 1–6 daily, dose 2MedDRA: Mass, Oedema peripheral — Feeling: Good · FeverFree text: Hard Swollen mass in underarmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Survey response — days 1–6 daily, dose 2MedDRA: Oedema peripheral — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: Swelling in underarmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Survey response — days 1–6 daily, dose 2MedDRA: Oedema peripheral — Feeling: GoodFree text: Swelling in underarmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-19
- 2021-05-20
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-08-13
- 2021-11-12
-
2022-01-19
Dose 3 — Pfizer-BioNTech
-
2022-01-19
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-01-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-21
- 2022-01-22
- 2022-01-23
- 2022-01-24
-
2022-01-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-26
- 2022-02-02
- 2022-02-09
- 2022-02-16
- 2022-02-23
- 2022-03-02
- 2022-04-20
-
2022-07-20
Survey response — 6 months, dose 3MedDRA: Ageusia, COVID-19, Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: Positive for covid. Fatigue and no tasteMedDRA releases: 2024-11 · check-in free text available
- 2023-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Pfizer-BioNTech | |
| 2 | 2021-05-14 | Pfizer-BioNTech | |
| 3 | 2022-01-19 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Hard Swollen mass in underarm
Systemic reaction (other): Swelling in underarm
Systemic reaction (other): Swelling in underarm
Release 12 — 6 months, dose 3
Symptoms: Positive for covid. Fatigue and no taste
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SRO | Mass | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release